Skip to search formSkip to main contentSkip to account menu

APE Regimen

A regimen consisting of cytarabine, cisplatin and etoposide, used for the treatment of recurrent and refractory, childhood Hodgkin's lymphoma.
National Institutes of Health

Related topics

Related topics

3 relations
CisplatinCytarabineEtoposide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
[Primary choriocarcinoma of the maxillary gingival].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)